Vernalis Share Discussion Threads

[4screws] 10/2/2012 20:11

ffp and jp2011 is the combined voiew then that we are better in....will we be offered the chance to buy at 20p and if so why would people buy today, why did they not wait until after the placing....for a nieve hlolder who bought in the british biotech days I value your opinions.

Thanks.

[ffp] 10/2/2012 19:30

£4.50 here

[4screws] 10/2/2012 19:23

take a long time then to get to £2.25 which is break even ...oooopppppppppsssssssss

[ffp] 10/2/2012 19:21

JP2011 >>> Good post, thank you. So we are either in or sell em?

[jarbie] 10/2/2012 15:36

Beware of the share dilution which will lower the share price proportionally
as has been the case on every other previous occasion without fail
in this case for every 16 shares there will be 16+47=63 shares
ie 63:16= 3.9, say a dilution of 4 - the collaboration will enhance the share price value,
say double it - thus share price post the offer of 20x2:4= 10p approximately
I may be wrong of-course - DYOR please

[robdance] 10/2/2012 15:31

Always a concern that this will now drift back to the 20p open offer price !!

[saud2237] 10/2/2012 11:18

Time to pop - Should go up !

[saud2237] 10/2/2012 10:07

Vernalis and Tris Pharma announce collaboration to develop and commercialize novel products for the US prescription cough/cold market



Vernalis plc (Vernalis), a UK development stage pharmaceutical company listed on the London Stock Exchange (LSE:VER) and Tris Pharma Inc (Tris) a privately held US specialty pharmaceutical company based in Monmouth Junction, New Jersey, today announce an exclusive licensing agreement to develop and commercialize multiple novel products focused on the US prescription cough/cold market.



Under the terms of the agreement Tris, using its proprietary technology, will develop, on behalf of Vernalis, up to six New Drug Applications (NDAs). Tris will undertake and fund the development work and Vernalis will pay development milestones to Tris on each product as they successfully progress through clinical development. Vernalis will acquire and then commercialize these products on approval in the US and pay a sales-based royalty to Tris.



Ian Garland, CEO of Vernalis commented "I am exceptionally pleased to be able to announce this collaboration with Tris today. This transaction is fundamental in transitioning Vernalis into a diversified and self-sustaining pharmaceutical company. The US cough/cold prescription market is a market that we know extremely well and Tris is a uniquely positioned development partner, with proven capabilities validated by multiple NDA approvals."



Ketan Mehta, CEO of Tris added "The US cough and cold market has been ripe for innovation and when you consider that market research shows most adults prefer long lasting relief in the form of a liquid, rather than solid dose, our technology is well positioned to address this market. We are delighted to partner with Vernalis as they have shown unique understanding of this space in the marketplace."

[saud2237] 10/2/2012 09:52

This will rocket past 30p today

[saud2237] 10/2/2012 09:46

What a news !

[mudbath] 10/2/2012 09:37

I said some thing was cooking .
Where is the share price going from here.?
Hopefully we should see a return to 40 pence ++ over coming months.

[fhmktg] 10/2/2012 09:34

I'm a member of that select band as well, but just maybe Fellner can bring back some hope?

[mrphil] 10/2/2012 09:10

Had some fun with this one over the years starting way back in the British Biotech days. Original investment now down 95% and all but worthless, but for some reason I'm still interested in hanging on in there!

[curlly] 10/2/2012 08:30

Can't make out why we are in au so long

[curlly] 10/2/2012 08:21

Mirabeau

Looks like about 442,000000

[mirabeau] 10/2/2012 08:13

How many shares in issue now then curlly? Any idea?

ta

[curlly] 10/2/2012 08:12

And we are still in au

[curlly] 10/2/2012 08:09

Goooooooooooooo baby

[curlly] 10/2/2012 07:39

So yes they must think the the price will rise with this news
And with the placeing at 20p aswell i think we are on to a winner.

[mirabeau] 10/2/2012 07:36

Exactly. You may as well buy in the market without all the hassle of forms etc.

It's fully underwritten which is a very good sign for the company and an expression of confidence

[knigel] 10/2/2012 07:31

s/b "but unless the share price climbs"...

[knigel] 10/2/2012 07:31

So Ver is having a 20p open offer placing, but until the share price climbs, there's no point taking it up, is there???

[mudbath] 08/2/2012 15:40

Anyone mind if I start a new VER thread,hopefully to coincide with an share price upturn?